Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Treatment of Recurrent or Persistent AML/MDS After Allogeneic Hematopoietic Cell Transplantation with Azacitidine.

Jennifer Vaughn, MD, MSPH, Barry Storer, PhD, Marco Mielcarek, MD, Edus H. Warren, III, MD, PhD, Paul J. Martin, MD, Brenda M. Sandmaier, MD, Elihu H. Estey, MD, Rainer Storb, MD, H. Joachim Deeg, MD, Bart Lee Scott, MD

Blood (2010) 116 (21): 1288.

https://doi.org/10.1182/blood.V116.21.1288.1288

Published: 2010

Journal Articles

Myelodisplastic Syndrome: Is It Associated or Is It a Precursor of Myeloid Malignancies?.

Giorgio Corinaldesi, MD, PhD, Christian Corinaldesi, MD

Blood (2007) 110 (11): 4592.

https://doi.org/10.1182/blood.V110.11.4592.4592

Published: 2007

Journal Articles

Study on the Relations between HLA-Class II Antigens and Idiophatic Thrombocitopenic Purpura in Adults.

Raquel de Paz, MD, PhD, Pedro Cano, MD, PhD, Emilio Gomez de la Concha, MD, PhD, Jose Antonio Rodriguez Montes, MD, PhD, Fernando Hernandez-Navarro, MD, PhD

Blood (2004) 104 (11): 3947.

https://doi.org/10.1182/blood.V104.11.3947.3947

Published: 2004

Journal Articles

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

Yogen Saunthararajah, Ryotaro Nakamura, Jun-Mo Nam, Jamie Robyn, Fausto Loberiza, Jaroslaw P. Maciejewski, Toni Simonis, Jeffrey Molldrem, Neal S. Young, A. John Barrett

Blood (2002) 100 (5): 1570–1574.

https://doi.org/10.1182/blood.V100.5.1570.h81702001570_1570_1574

Published: 2002

Journal Articles

Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens

Hoon Kook, Antonio M. Risitano, Weihua Zeng, Marcin Wlodarski, Craig Lottemann, Ryotaro Nakamura, John Barrett, Neal S. Young, Jaroslaw P. Maciejewski

Blood (2002) 99 (10): 3668–3675.

https://doi.org/10.1182/blood.V99.10.3668

Published: 2002

Journal Articles

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

Jaroslaw P. Maciejewski, Dean Follmann, Ryotaro Nakamura, Yogen Saunthararajah, Candido E. Rivera, Toni Simonis, Kevin E. Brown, John A. Barrett, Neal S. Young

Blood (2001) 98 (13): 3513–3519.

https://doi.org/10.1182/blood.V98.13.3513

Published: 2001

NARROW

Treatment of Recurrent or Persistent AML/MDS After Allogeneic Hematopoietic Cell Transplantation with Azacitidine.

Myelodisplastic Syndrome: Is It Associated or Is It a Precursor of Myeloid Malignancies?.

Study on the Relations between HLA-Class II Antigens and Idiophatic Thrombocitopenic Purpura in Adults.

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

Email alerts

ASH Publications

American Society of Hematology

Treatment of Recurrent or Persistent AML/MDS After Allogeneic Hematopoietic Cell Transplantation with Azacitidine.

Myelodisplastic Syndrome: Is It Associated or Is It a Precursor of Myeloid Malignancies?.

Study on the Relations between HLA-Class II Antigens and Idiophatic Thrombocitopenic Purpura in Adults.

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only